0001209191-13-044599.txt : 20130917
0001209191-13-044599.hdr.sgml : 20130917
20130917161343
ACCESSION NUMBER: 0001209191-13-044599
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130916
FILED AS OF DATE: 20130917
DATE AS OF CHANGE: 20130917
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6173416100
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MUELLER PETER
CENTRAL INDEX KEY: 0001256126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 131101427
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-09-16
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001256126
MUELLER PETER
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST.
CAMBRIDGE
MA
02139
0
1
0
0
EVP, Global R&D, CSO
Common Stock
2013-09-16
4
M
0
7500
18.93
A
151900
D
Common Stock
2013-09-16
4
S
0
3085
76.40
D
148815
D
Common Stock
2013-09-16
4
S
0
2895
77.44
D
145920
D
Common Stock
2013-09-16
4
S
0
1320
78.38
D
144600
D
Common Stock
2013-09-16
4
S
0
200
79.08
D
144400
D
Common Stock
4770
I
401(k)
Common Stock
5568
I
Revocable Trust
Stock Option
18.93
2013-09-16
4
M
0
7500
0.00
D
2018-02-06
Common Stock
7500
10500
D
Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $76.40 (range $75.97 to $76.93).
Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $77.44 (range $76.97 to $77.96).
Open market sales reported on this line occurred at a weighted average price of $78.38 (range $78.03 to $78.89).
Fully vested.
Kenneth L. Horton, Attorney-In-Fact
2013-09-17